Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInterest Coverage RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on EquityTimes Interest Earned

Acro Biomedical (ACBM) Return on Capital Employed (2017 - 2025)

Acro Biomedical (ACBM) has 9 years of Return on Capital Employed data on record, last reported at 0.39% in Q4 2025.

  • For Q4 2025, Return on Capital Employed rose 36.0% year-over-year to 0.39%; the TTM value through Dec 2025 reached 0.39%, up 36.0%, while the annual FY2025 figure was 0.41%, 38.0% up from the prior year.
  • Return on Capital Employed reached 0.39% in Q4 2025 per ACBM's latest filing, up from 0.29% in the prior quarter.
  • Across five years, Return on Capital Employed topped out at 7.4% in Q4 2023 and bottomed at 622.12% in Q3 2023.
  • Average Return on Capital Employed over 5 years is 41.5%, with a median of 7.29% recorded in 2021.
  • Peak YoY movement for Return on Capital Employed: crashed -60314bps in 2023, then surged 59703bps in 2024.
  • A 5-year view of Return on Capital Employed shows it stood at 2.68% in 2021, then tumbled by -1176bps to 34.17% in 2022, then skyrocketed by 122bps to 7.4% in 2023, then crashed by -100bps to 0.03% in 2024, then soared by 1191bps to 0.39% in 2025.
  • Per Business Quant database, its latest 3 readings for Return on Capital Employed were 0.39% in Q4 2025, 0.29% in Q3 2025, and 0.04% in Q2 2025.